Top Markets
Coin of the day
Abiomed, Inc. Abiomed, Inc.

Abiomed, Inc.

ABMD
Classifica tra le azioni #1388
Abiomed, Inc. specializes in the creation and distribution of advanced medical... Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while also offering ongoing care for these individuals. Its product portfolio includes various devices from the Impella family. The Impella 2.5 is a tiny percutaneous heart pump featuring an integrated motor and sensors, alongside the Impella CP, which is utilized by interventional cardiologists in catheterization labs and by cardiac surgeons during operations. Other Impella models such as the 5.0, LD, and 5.5 are also percutaneous micro heart pumps, primarily employed in surgical settings. The Impella RP is a percutaneous catheter-based axial flow pump. Beyond the pumps, Abiomed offers the Impella SmartAssist platform, which leverages optical sensors for precise pump placement and uses algorithms to enhance native heart function assessment during patient weaning. Its Impella Connect system provides secure, cloud-based remote monitoring of the automated Impella controller for medical staff. The company also markets the OXY-1 System, a portable device for external respiratory support. Furthermore, Abiomed is actively developing several innovations, including the Impella ECP pump for high blood flow rates, the Impella XR Sheath for smaller access during Impella procedures, the Impella BTR percutaneous micro heart pump, and preCARDIA, a catheter-based superior vena cava therapy system aimed at quickly addressing acute decompensated heart failure. Abiomed distributes its products globally through its dedicated direct sales and clinical support teams, reaching regions such as the United States, Japan, Canada, countries across Europe (including Germany and France), Latin America, the Asia-Pacific, and the Middle East. Founded in 1981 and headquartered in Danvers, Massachusetts, Abiomed, Inc. has been operating as a subsidiary of Johnson & Johnson since December 22, 2022.
Prezzo delle azioni
$381.02
Ultima sincronizzazione: 2022-12-23
Capitalizzazione di mercato
$17.18B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia Abiomed, Inc. (ABMD)

Categoria

Storico del prezzo dell'azione per Abiomed, Inc. (ABMD)
Prezzo di chiusura più alto: $379.81 il 2022-12-01

Prezzo di chiusura più basso: $5.54 il 1987-07-01
Storico del prezzo dell'azione di Abiomed, Inc. dal 1987 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2022 16.10%
2021 14.41%
2020 60.46%
2019 -43.20%
2018 64.57%
2017 66.53%
2016 33.37%
2015 132.04%
2014 36.12%
2013 104.83%
2012 -31.56%
2011 96.23%
2010 14.02%
2009 -44.56%
2008 6.85%
2007 9.08%
2006 46.56%
2005 -35.99%
2004 91.48%
2003 75.82%
2002 -75.54%
2001 -27.10%
2000 18.11%
1999 318.77%
1998 -42.18%
1997 31.66%
1996 1.04%
1995 137.38%
1994 -33.27%
1993 -33.79%
1992 -28.45%
1991 178.66%
1990 -48.82%
1989 28.81%
1988 65.32%
1987 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$116.66 -11.53%
US
$328.27 -16.02%
US
$92.91 0.95%
IE
$48.98 -53.41%
US
$47.58 -13.88%
DE